Improved survival in cervical cancer patients receiving care at National Cancer Institute-designated cancer centers.

Publication Year: 2022

DOI:
10.1002/cncr.34404

PMCID:
PMC9544648

PMID:
35917201

Journal Information

Full Title: Cancer

Abbreviation: Cancer

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICTS OF INTEREST Jyoti S. Mayadev reports consulting honoraria from Varian Medical Systems, Merck, Astra Zeneca, and Primmune Bio and grants from NCI, NRG Oncology, and GOG Foundation. The other authors made no disclosure."

Evidence found in paper:

"FUNDING INFORMATION National Cancer Institute at the National Institutes of Health grant numbers U54CA132379, U54CA132384, and 5P30CA023100."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025